SEC Filing Summary: Ra Medical Systems, Inc. (RMED)
Business Context and Reporting Period
This Form 8-K was filed by Ra Medical Systems, Inc. on November 15, 2021. The filing serves as a current report to announce the company's financial results for the three and nine months ended September 30, 2021. The registrant is an emerging growth company incorporated in Delaware, with principal executive offices in Carlsbad, California.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Item 2.02 explicitly states that the detailed financial results are contained in a press release attached as Exhibit 99.1, which is incorporated by reference but not reproduced within the body of this 8-K document.
Material Changes
No specific material changes versus prior periods are detailed in the text of this filing. The document functions solely as a notification that the results for the period ended September 30, 2021, have been issued.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies. These elements are presumed to be located in the referenced press release (Exhibit 99.1).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 15, 2021) for actual revenue, net loss, and cash position figures.
- Verify the specific year-over-year and quarter-over-quarter growth rates mentioned in the press release.
- Check the press release for any updated full-year 2021 guidance or operational milestones.
- Confirm the company's cash runway and burn rate as disclosed in the full financial statement.